Author: International conference on the adjuvanttherapy of cancer, 1st, tucson, 1977
Publisher:
ISBN:
Category :
Languages : en
Pages : 0
Book Description
Adjuvant Therapy of Cancer : Proceedings of the International Conference on the Adjuvant Therapy of Cancer, Held in Tucson, Arizona, Usa, March 2-5, 1977
Adjuvant Therapy of Cancer
Author: Sydney E. Salmon
Publisher:
ISBN:
Category : Antineoplastic agents
Languages : en
Pages : 646
Book Description
Publisher:
ISBN:
Category : Antineoplastic agents
Languages : en
Pages : 646
Book Description
Proceedings of the International Conference on the Adjuvant Therapy of Cancer Held in Tucson, Arizona, USA, March 2 - 5, 1977
Author: Sydney E. Salmon
Publisher:
ISBN:
Category :
Languages : en
Pages : 646
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 646
Book Description
Adjuvant Therapy of Cancer
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 0
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 0
Book Description
Adjuvant Therapies of Cancer
Author: Georges Mathe;&AAe;
Publisher: Springer Science & Business Media
ISBN: 3642816851
Category : Medical
Languages : en
Pages : 404
Book Description
Transplantation of syngeneic (donor is a monozygous twin) or allogeneic (donor is an HLA-identical sibling) marrow provides the opportunity for aggressive antileukemic therapy without regard to marrow toxicity. Until 1975, marrow transplantation was carried out only after failure of all other therapy. Consequently, most patients were in advanced relapse. Six of 16 recipients of syngeneic marrow and 13 of 100 recipients of allogeneic marrow are still in remission after 5. 5-10 years [3, 7]. An actuarial survival curve of the first 100 patients grafted in Seattle after conditioning with cyclophos phamide (60 mg/kg on each of 2 successive days) and total body irradiation (1,000 rad) showed three periods of interest: (1) The first 4 months showed a rapid loss of patients associated with advanced illness, graft-versus-host disease, infections (in particular interstitial pneumonias), and recurrent leukemia; (2) from 4 months to 2 years, the curve showed a much slower rate of decline attributable primarily to recurrent leukemia; and (3) from 2-10 years, the curve was almost flat with a negligible loss of patients and no recurrent leukemia. This flat portion of the curve corresponded to 13% of the patients and indicates a strong probability that the majority of these survivors are cured of their disease [8]. Attempts at reducing the incidence of leukemic relapse after transplantation were made by a number of marrow transplant groups by added chemotherapy.
Publisher: Springer Science & Business Media
ISBN: 3642816851
Category : Medical
Languages : en
Pages : 404
Book Description
Transplantation of syngeneic (donor is a monozygous twin) or allogeneic (donor is an HLA-identical sibling) marrow provides the opportunity for aggressive antileukemic therapy without regard to marrow toxicity. Until 1975, marrow transplantation was carried out only after failure of all other therapy. Consequently, most patients were in advanced relapse. Six of 16 recipients of syngeneic marrow and 13 of 100 recipients of allogeneic marrow are still in remission after 5. 5-10 years [3, 7]. An actuarial survival curve of the first 100 patients grafted in Seattle after conditioning with cyclophos phamide (60 mg/kg on each of 2 successive days) and total body irradiation (1,000 rad) showed three periods of interest: (1) The first 4 months showed a rapid loss of patients associated with advanced illness, graft-versus-host disease, infections (in particular interstitial pneumonias), and recurrent leukemia; (2) from 4 months to 2 years, the curve showed a much slower rate of decline attributable primarily to recurrent leukemia; and (3) from 2-10 years, the curve was almost flat with a negligible loss of patients and no recurrent leukemia. This flat portion of the curve corresponded to 13% of the patients and indicates a strong probability that the majority of these survivors are cured of their disease [8]. Attempts at reducing the incidence of leukemic relapse after transplantation were made by a number of marrow transplant groups by added chemotherapy.
The NLM Technical Bulletin
Author:
Publisher:
ISBN:
Category : Medical libraries
Languages : en
Pages : 360
Book Description
Publisher:
ISBN:
Category : Medical libraries
Languages : en
Pages : 360
Book Description
Current Catalog
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1068
Book Description
First multi-year cumulation covers six years: 1965-70.
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1068
Book Description
First multi-year cumulation covers six years: 1965-70.
Adjuvant therapy of cancer V
Author: Sydney E. Salmon
Publisher:
ISBN: 9780808918004
Category :
Languages : en
Pages : 806
Book Description
Publisher:
ISBN: 9780808918004
Category :
Languages : en
Pages : 806
Book Description
Adjuvant Therapy of Cancer IV
Author: Stephen E. Jones
Publisher:
ISBN:
Category :
Languages : en
Pages : 699
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 699
Book Description
Catalog of Copyright Entries. Third Series
Author: Library of Congress. Copyright Office
Publisher: Copyright Office, Library of Congress
ISBN:
Category : Copyright
Languages : en
Pages : 1898
Book Description
Publisher: Copyright Office, Library of Congress
ISBN:
Category : Copyright
Languages : en
Pages : 1898
Book Description